Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024

Rhea-AI Summary

Assertio Holdings, a pharmaceutical company known for its commercial capabilities and unique product offerings, announced its participation in the Sidoti Small Cap Conference on June 12, 2024. The event will be held virtually, with Ajay Patel, the Chief Financial Officer, presenting at 10:45 am Eastern Time. Investors can access the presentation through a webcast available on Assertio's investor relations website. Additionally, 1x1 meetings can be scheduled via Sidoti representatives or by contacting Assertio's investor relations.

Positive

• Assertio's participation in the Sidoti Small Cap Conference enhances visibility among potential investors.
• The virtual format of the presentation increases accessibility for a broader audience.
• Ajay Patel, CFO, presenting at the conference may provide investors with critical financial insights and strategic direction.

Negative

• The impact of the presentation on the stock price (ASRT) remains uncertain and dependent on investor reception.
• No new product announcements or significant financial data updates were provided in the PR.
• The PR lacks detailed financial performance metrics, which might be necessary for thorough investor analysis.

LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will present at the Sidoti Small Cap Conference, which will take place virtually on June 12, 2024.

The Company will present at 10:45 am Eastern Time on Wednesday, June 12, 2024. To join the presentation, please visit the webcast available online at https://investor.assertiotx.com/.

Additionally, investors participating in the conference can request a 1x1 meeting via their Sidoti representative, or contact Assertio investor relations via mkreps@darrowir.com.

About Assertio

Assertio is a commercial pharmaceutical company offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.

Forward Looking Statements

Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio, including risks related to our ability to realize the benefits from our operating model, deliver or execute on our business strategy, including to expand or diversify our asset base and market reach and drive cash flows and growth, successfully integrate new assets, and explore new business development initiatives. All statements other than historical facts may be forward-looking statements and can be identified by words such as “anticipate,” “believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,” “objective,” “opportunity,” “outlook,” “plan,” “position,” “potential,” “predict,” “project,” “prospective,” “pursue,” “seek,” “should,” “strategy,” “target,” “would,” “will,” “aim” or other similar expressions that convey the uncertainty of future events or outcomes and are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of Assertio, including the risks described in Assertio’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”) and in other filings Assertio makes with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While Assertio may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this press release whether as a result of new information or future events, except as may be required by applicable law.

Investor Contact

Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com

FAQ

What conference will Assertio participate in on June 12, 2024?

Assertio will participate in the Sidoti Small Cap Conference on June 12, 2024.

When will Assertio present at the Sidoti Small Cap Conference?

Assertio will present at 10:45 am Eastern Time on June 12, 2024.

How can investors access Assertio's presentation at the Sidoti Small Cap Conference?

Investors can access the presentation via a webcast available on Assertio's investor relations website.

Can investors schedule 1x1 meetings with Assertio during the Sidoti Small Cap Conference?

Yes, investors can request 1x1 meetings via their Sidoti representative or by contacting Assertio investor relations.